Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma

Figure 1

HDAC inhibitors exert their tumor-suppressive role through various mechanisms. Green arrows: procedures enhanced by HDAC inhibitors. Red arrows: procedures blocked by HDAC inhibitors (created with http://Biorender.com). HDAC: histone deacetylase; PR: progesterone receptor; MIG6: mitogen-inducible gene 6; VEGF: vascular endothelial growth factor.